Seres Therapeutics, Inc.
MCRB
$19.44
$1.126.11%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -36.29% | -47.07% | -75.94% | -60.67% | -68.96% |
Total Receivables | -93.76% | -62.78% | -- | -- | 146.08% |
Inventory | -- | -- | -- | -- | 892.45% |
Prepaid Expenses | -66.67% | -3.00% | -27.78% | -32.92% | -27.03% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -67.38% | -60.00% | -77.95% | -65.98% | -40.59% |
|
|||||
Total Current Assets | -67.38% | -60.00% | -77.95% | -65.98% | -40.59% |
Net Property, Plant & Equipment | -28.63% | -28.35% | -14.43% | -27.49% | -9.85% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -83.07% | -83.04% | -88.43% | -52.21% | 146.59% |
Total Assets | -55.30% | -51.89% | -61.01% | -51.39% | -20.83% |
|
|||||
Total Accounts Payable | -54.25% | -58.46% | 12.03% | -7.86% | -62.78% |
Total Accrued Expenses | -86.58% | -84.49% | -52.38% | -9.68% | 76.61% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.08% | 2.45% | 55.25% | 32.90% | 68.10% |
Total Finance Division Other Current Liabilities | -73.62% | -68.67% | -73.48% | -31.22% | 45.71% |
Total Other Current Liabilities | -73.62% | -68.67% | -73.48% | -31.22% | 45.71% |
Total Current Liabilities | -71.43% | -68.19% | -58.22% | -18.17% | 39.00% |
|
|||||
Total Current Liabilities | -71.43% | -68.19% | -58.22% | -18.17% | 39.00% |
Long-Term Debt | -- | -- | -- | -- | 1.74% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -22.77% | -22.10% | -9.48% | -18.69% | -5.41% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -97.99% | -98.05% | -98.35% | -95.16% | -1.36% |
Total Liabilities | -72.88% | -71.64% | -68.76% | -59.56% | 6.52% |
|
|||||
Common Stock & APIC | 3.53% | 3.89% | 6.27% | 7.00% | 5.75% |
Retained Earnings | 8.18% | 7.16% | 0.01% | -2.72% | -18.23% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 137.84% | 184.48% | 130.73% | 258.16% | -485.04% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 137.84% | 184.48% | 130.73% | 258.16% | -485.04% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 137.84% | 184.48% | 130.73% | 258.16% | -485.04% |
|